Product Program year 2019 Source: CMS Open Payments

Trilogy 100

Device Pulmonary/Respiratory Diseases

Open in the dashboard

General payments

$136,136

4,485 payments

Research payments

$0

0 payments

Through program year 2019, $136,136 in general payments and $0 in research payments were reported against Trilogy 100 (Pulmonary/Respiratory Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $136,136 4,485

Breakdown

Who paid General payments · program year 2019
  1. Philips Electronics North America Corporation $136,136 4,485 payments
Top recipients General payments · program year 2019
  1. Charles Love Clinical Cardiac Electrophysiology · Baltimore, MD $6,050 4% · 8 payments
  2. David Classen Infectious Disease · Salt Lake City, UT $3,496 3% · 3 payments
  3. Craig Walker Interventional Cardiology · Houma, LA $2,557 2% · 18 payments
  4. John Fallon Anatomic Pathology & Clinical Pathology · Greenville, NC $2,213 2% · 5 payments
  5. John Bach Physical Medicine & Rehabilitation · Newark, NJ $1,500 1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pulmonary Disease Internal Medicine $28,021 21% · 915 practitioners
  2. Interventional Cardiology Internal Medicine $22,010 16% · 296 practitioners
  3. Cardiovascular Disease Internal Medicine $11,817 9% · 193 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $9,280 7% · 39 practitioners
  5. Internal Medicine $7,129 5% · 266 practitioners

The top 5 of 89 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. New York $15,650 11% · 324 recipients
  2. Florida $12,250 9% · 290 recipients
  3. California $11,927 9% · 375 recipients
  4. Texas $10,591 8% · 301 recipients
  5. Maryland $8,252 6% · 30 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

4,485 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record